Oak Family Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
907
-20
-2% -$20.4K 0.28% 62
2026
Q1
$853K Sell
927
-1,425
-61% -$1.44M 0.24% 64
2025
Q4
$2.53M Sell
2,352
-242
-9% -$231K 0.69% 45
2025
Q3
$1.98M Buy
+2,594
New +$1.93M 0.49% 50

Other funds holding LLY

Oak Family Advisors's LLY Position: Q2 2026 in Review

Oak Family Advisors reduced its Eli Lilly (LLY) stake by 2.2% in Q2 2026, selling an estimated $20.4K and leaving 907 shares worth $1.09M. The position accounts for 0.28% of the portfolio, ranked #62.

Oak Family Advisors first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.53M in Q4 2025. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Oak Family Advisors held 907 shares of Eli Lilly worth $1.09M as of Q2 2026.
  • Oak Family Advisors sold 20 Eli Lilly shares in Q2 2026, an estimated $20.4K.
  • Eli Lilly made up 0.28% of Oak Family Advisors's portfolio in Q2 2026, its #62 holding.
  • Oak Family Advisors first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • Oak Family Advisors's Eli Lilly position peaked at $2.53M in Q4 2025.
  • 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Oak Family Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.